This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Incyte Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Jörg Wenzel
Introduction
Jörg Wenzel is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of skin diseases. His work focuses on innovative therapeutic methods that aim to improve patient outcomes.
Latest Patents
Wenzel holds a patent for the "Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)." This patent outlines methods for treating these diseases by administering a therapeutically effective amount of a JAK1 selective inhibitor or a pharmaceutically acceptable salt thereof. His innovative approach addresses the needs of patients suffering from these conditions.
Career Highlights
Jörg Wenzel is associated with Incyte Corporation, a leading biopharmaceutical company. His work at Incyte has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Wenzel has worked closely with his coworker, Paul Smith, to advance their research initiatives. Their collaboration has been instrumental in driving forward the innovative treatments they are developing.
Conclusion
Jörg Wenzel's contributions to the field of medicine through his patent and work at Incyte Corporation highlight his commitment to improving patient care. His innovative approaches continue to pave the way for advancements in the treatment of skin diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile